Core 1: Biospecimen Core
核心 1:生物样本核心
基本信息
- 批准号:10227749
- 负责人:
- 金额:$ 23.25万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-09-14 至 2023-07-31
- 项目状态:已结题
- 来源:
- 关键词:African AmericanArchivesBarrett EsophagusBiological AssayBiological MarkersBloodBlood specimenCenter for Translational Science ActivitiesClinicalClinical MedicineClinical TrialsCollaborationsCollectionColon CarcinomaColonic NeoplasmsComprehensive Cancer CenterConfidentiality of Patient InformationConsultationsCore FacilityCustomDNADataData SetDevelopmentDissectionEnsureEsophageal mucous membraneEsophagusExperimental DesignsExperimental PathologyFacultyFormalinFormulationFreezingFresh TissueFrozen SectionsGenerationsGenesGlutamineGoalsGrantHistologyHumanHuman ResourcesImmunohistochemistryIn Situ HybridizationIndividualInformation DisseminationInstitutionInstitutional Review BoardsLaboratoriesLinkMalignant neoplasm of esophagusMalignant neoplasm of gastrointestinal tractManuscriptsMedical centerMetabolismMicrodissectionModificationMolecularMolecular AnalysisMorphologyMusMutateNeoplasm MetastasisNeoplasmsOutcomeOxidoreductasePIK3CA geneParaffinParaffin EmbeddingParticipantPathologicPathologyPatientsPharmacologyPilot ProjectsPlayProceduresProcessProstaglandinsProtocols documentationQuality ControlRNAResearchResearch PersonnelResearch Project GrantsResourcesRoleSamplingScheduleServicesSpecimenTechniquesTechnologyTest ResultTestingTissue EmbeddingTissue MicroarrayTissue ProcurementsTissue SampleTissuesTranslational ResearchTumor Suppressor GenesUniversity HospitalsVimentinWorkWritingbasebiological specimen archivesblood fractionationcareercentral databaseclinical databasecolon carcinogenesiscost effectivedesignexperiencefollow-upgastrointestinalhuman tissueinsightinterestlaser capture microdissectionmeetingsmemberprogramsprospectiveresearch studyskillssuccesstechnology developmenttissue archivetissue processingtranslational cancer researchtranslational study
项目摘要
PROJECT SUMMARY/ABSTRACT
The Biospecimen Core will continue to provide high quality annotated specimens and expert pathology
consultation to enhance the projects of Case GI SPORE investigators. This process will continue the
longstanding, successful, collaborations between the members of the Core and the individual project
investigators. During the course of these collaborations the Core has developed an extensive biospecimen
archive derived from over 13,000 patients. Previously, the Core has supplied high quality annotated specimens
leading to the discovery of 15-Prostaglandin Dehydrogenase as an important tumor suppressor gene in colon
carcinogenesis – the basis of Project 1; the African American colon cancer 15 gene-panel – the basis of Project
2; methylated vimentin as a biomarker of Barrett's Esophagus – the basis of Project 3; and the discovery of
unique glutamine metabolism in PIK3CA mutated colon cancers – the basis of Project 4. The Core also provided
significant support to the SPORE's Career Enhancement and Pilot Projects Programs. The Core has an
extensive archive of colon neoplasms from over 4,800 patients including 2,292 primary colon cancers of known
pathologic stage and databased clinical follow-up as well as a substantial number of cancer metastases. Frozen
material from 1053 of these cases is also banked with matched normal controls. The Core also has 350
esophageal cancers and Barrett's esophagus paraffin specimens as well as 134 frozen esophageal specimens.
Many of these samples have undergone extensive molecular analysis – enabling sophisticated translational
studies. The Core works with the Case Comprehensive Cancer Center to make available to the SPORE a wide
variety of techniques and technologies in a cost effective manner. The Core will organize all prospective GI
biospecimen procurements and distribution to SPORE investigators as well as provide access to its existing
tissue archive resource. The Core will support the projects of this application by identification of tissues of interest
to investigators both from the Core archive and from prospective accrual. The Core will provide histopathological
quality control for tissue sections, along with project specific morphology case reviews and will oversee and
provide longitudinal follow-up of clinical outcomes linked to these tissues. The Core will also provide tissue
microarray sections for tissue targets of interest, expertise in immunohistochemistry and in situ hybridization
assessment and samples appropriate for specific studies. The primary objective is to provide a resource that
contributes significantly to the translational goals and endpoints of the individual projects and to facilitate
cooperation between other GI SPOREs.
项目概要/摘要
生物样本核心将继续提供高质量的带注释样本和专家病理学
旨在加强 Case GI SPORE 调查员项目的磋商将继续进行。
核心成员与单个项目之间长期、成功的合作
在这些合作过程中,核心开发了广泛的生物样本。
此前,Core 已经提供了来自超过 13,000 名患者的高质量注释样本。
导致发现 15-前列腺素脱氢酶作为结肠中重要的抑癌基因
致癌作用 – 项目 1 的基础;非裔美国人结肠癌 15 基因组 – 项目的基础
2;甲基化波形蛋白作为巴雷特食管的生物标志物——项目 3 的基础和发现;
PIK3CA 突变结肠癌中独特的谷氨酰胺代谢——项目 4 的基础。核心还提供了
对 SPORE 职业提升和试点项目计划的大力支持。
来自 4,800 多名患者的结肠肿瘤的广泛档案,其中包括 2,292 例已知的原发性结肠癌
病理分期和数据库临床随访以及大量癌症转移。
其中 1053 个病例的材料也与匹配的正常对照一起存储。核心还有 350 个病例。
食管癌和巴雷特食管石蜡标本以及 134 份冷冻食管标本。
其中许多样品进行了广泛的分子分析——实现复杂的转化
The Core 与 Case 综合癌症中心合作,为 SPORE 提供广泛的研究。
核心将以具有成本效益的方式组织所有未来的地理标志。
生物样本采购和分发给 SPORE 研究人员,并提供对其现有资源的访问
组织档案资源。核心将通过识别感兴趣的组织来支持该应用程序的项目。
核心档案和预期应计的研究人员将提供组织病理学信息。
组织切片的质量控制,以及项目特定形态学案例审查,并将监督和
提供与这些组织相关的临床结果的纵向随访。核心还将提供组织。
感兴趣的组织靶标的微阵列切片、免疫组织化学和原位杂交方面的专业知识
适合特定研究的评估和样本主要目标是提供资源
为各个项目的转化目标和终点做出重大贡献,并促进
其他 GI SPORE 之间的合作。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JOSEPH EDWARD WILLIS其他文献
JOSEPH EDWARD WILLIS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JOSEPH EDWARD WILLIS', 18)}}的其他基金
Validation of Methylated Vimentin as a Diagnostic Test for Barrett's Esophagus
甲基化波形蛋白作为巴雷特食管诊断测试的验证
- 批准号:
9923576 - 财政年份:2016
- 资助金额:
$ 23.25万 - 项目类别:
Project 2: Translational Significance of a Mutational Signature of African American Colon Cancers
项目 2:非裔美国人结肠癌突变特征的转化意义
- 批准号:
10227753 - 财政年份:2011
- 资助金额:
$ 23.25万 - 项目类别:
Identification of Significant Race Associated Colon Cancer Drive Gene Mutations
显着种族相关结肠癌驱动基因突变的鉴定
- 批准号:
8097073 - 财政年份:2011
- 资助金额:
$ 23.25万 - 项目类别:
Patients Registry -Virtual Biorepository Core
患者登记处-虚拟生物样本库核心
- 批准号:
10153705 - 财政年份:2011
- 资助金额:
$ 23.25万 - 项目类别:
Identification of Significant Race Associated Colon Cancer Drive Gene Mutations
显着种族相关结肠癌驱动基因突变的鉴定
- 批准号:
8330850 - 财政年份:2011
- 资助金额:
$ 23.25万 - 项目类别:
相似国自然基金
零信任架构下的电子健康档案动态共享研究
- 批准号:72274077
- 批准年份:2022
- 资助金额:45 万元
- 项目类别:面上项目
科学基金档案资料信息化管理探索与实践研究
- 批准号:
- 批准年份:2022
- 资助金额:10 万元
- 项目类别:
胶州湾河口湿地盾纤亚纲纤毛虫的多样性研究与档案资料建立
- 批准号:
- 批准年份:2021
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于基金项目全生命周期的档案规范化管理探索与实践研究
- 批准号:52142301
- 批准年份:2021
- 资助金额:10 万元
- 项目类别:专项基金项目
医联体内电子健康档案应用绩效提升研究:影响因素、动力系统与治理机制
- 批准号:72164037
- 批准年份:2021
- 资助金额:28 万元
- 项目类别:地区科学基金项目
相似海外基金
Multi-site Gastrointestinal Cancer Detection by Stool DNA Methylation
通过粪便 DNA 甲基化进行多部位胃肠癌检测
- 批准号:
10443018 - 财政年份:2023
- 资助金额:
$ 23.25万 - 项目类别:
Cancer Prevention-Interception Targeted Agent Discovery Program at Fox Chase Cancer Center
福克斯蔡斯癌症中心的癌症预防-拦截靶向药物发现计划
- 批准号:
10505611 - 财政年份:2022
- 资助金额:
$ 23.25万 - 项目类别:
Genetic susceptibility to Barrett's esophagus: From GWAS to biology
巴雷特食管的遗传易感性:从 GWAS 到生物学
- 批准号:
10674348 - 财政年份:2021
- 资助金额:
$ 23.25万 - 项目类别:
Genetic susceptibility to Barrett's esophagus: From GWAS to biology
巴雷特食管的遗传易感性:从 GWAS 到生物学
- 批准号:
10365524 - 财政年份:2021
- 资助金额:
$ 23.25万 - 项目类别: